AMO PUERTO RICO MFG. INC.

Manufacturer adverse-event records for AMO PUERTO RICO MFG. INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2020–2026 · mid-book · quiet Death-code · balanced

Death-code intensity

AMO PUERTO RICO MFG. INC. is quieter on Death-coded events

Death-coded event_type rows are 0 of 10,713 (0.00% · quiet tercile among 443 manufacturers). Absolute volume is mid-book.

What the Death-code reading shows for AMO PUERTO RICO MFG. INC.

The standout signal for AMO PUERTO RICO MFG. INC. is Death-code intensity: 0.00% of 10,713 reports (quiet tercile), while absolute volume is mid-book.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for AMO PUERTO RICO MFG. INC.. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 9 device types, led in this extract by Malfunction at 7,124 (66.5% of event_type total). Peak single-year volume reaches 2,230 reports across 7 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

10,713
Total Reports
0
Event-type Death
3,589
Injury Reports
9
Device Types

Event Types

Malfunction 7,124 (66.5%)
Injury 3,589 (33.5%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

7,065 (65.6%)
Required Intervention 3,198 (29.7%)
Other 408 (3.8%)
R 45 (0.4%)
O 41 (0.4%)
H 6 (0.1%)
Hospitalization 6 (0.1%)

Yearly Trend

20
2020: 4
21
2021: 1,860
22
2022: 1,993
23
2023: 2,185
24
2024: 2,230
25
2025: 2,163
26
2026: 278